Biogen (BIIB) Other Working Capital Changes (2009 - 2026)

Biogen's Other Working Capital Changes history runs 18 years deep, the most recent figure standing at $89.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 66.36% year-over-year to $89.0 million; the TTM figure through Mar 2026 stood at $96.1 million (up 276.86% YoY), while the FY2025 annual figure was $60.6 million, up 115.66% from the prior year.
• Other Working Capital Changes was $89.0 million for Q1 2026 at Biogen, up from -$119.3 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $213.6 million in Q1 2022 to a low of -$149.9 million in Q3 2022.
• Historically, Other Working Capital Changes has averaged $11.8 million across 5 years, with a median of $22.0 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes tumbled 1445.36% in 2022, then jumped 379.89% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $34.9 million in 2022, then tumbled by 291.4% to -$66.8 million in 2023, then surged by 43.71% to -$37.6 million in 2024, then sank by 217.29% to -$119.3 million in 2025, then surged by 174.6% to $89.0 million in 2026.
• The last three Other Working Capital Changes figures came in at $89.0 million (Q1 2026), -$119.3 million (Q4 2025), and $104.4 million (Q3 2025), per Business Quant data.